Dual Blockade of Cyclic AMP Response Element- (CRE) and AP-1-directed Transcription by CRE-transcription Factor Decoy Oligonucleotide
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Alteration of gene transcription by inhibition of specific transcriptional regulatory proteins has important therapeutic potential. Synthetic double-stranded phosphorothioate oligonucleotides with high affinity for a target transcription factor can be introduced into cells as decoy cis-elements to bind the factors and alter gene expression. The CRE (cyclic AMP response element)-transcription factor complex is a pleiotropic activator that participates in the induction of a wide variety of cellular and viral genes. Because the CRE cis-element, TGACGTCA, is palindromic, a synthetic single-stranded oligonucleotide composed of the CRE sequence self-hybridizes to form a duplex/hairpin. Herein we report that the CRE-palindromic oligonucleotide can penetrate into cells, compete with CRE enhancers for binding transcription factors, and specifically interfere with CRE- and AP-1-directed transcription in vivo. These oligonucleotides restrained tumor cell proliferation, without affecting the growth of noncancerous cells. This decoy oligonucleotide approach offers great promise as a tool for defining cellular regulatory processes and treating cancer and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Cited by
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0534764100 · Cited by 340
Tischkau, S. A., Mitchell, J. W., Tyan, S.-H., Buchanan, G. F., & Gillette, M. U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209241200 · Cited by 295
Mabuchi, T., Kitagawa, K., Kuwabara, K., Takasawa, K., Ohtsuki, T., Xia, Z., Storm, D., Yanagihara, T., Hori, M., & Matsumoto, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09204.2001 · Cited by 266
Emerging avenues linking inflammation and cancer
Kundu, J. K., & Surh, Y.-J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.035 · Cited by 264
STAT3 as a therapeutic target in head and neck cancer
Leeman, R. J., Lui, V. W. Y., & Grandis, J. R. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.231 · Cited by 223
“(2006) 6(3) 237 CRE and AP-1, and has been shown to abrogate the proliferation of MCF-7 breast cancer cells [95].”
BackgroundSanak, M., Pierzchalska, M., Bazan-Socha, S., & Szczeklik, A. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.3.4051 · Cited by 202
Xie, F., Li, B. X., Kassenbrock, A., Xue, C., Wang, X., Qian, D. Z., Sears, R. C., & Xiao, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00468 · Cited by 179
Targeting CREB for Cancer Therapy: Friend or Foe
Xiao, X., Li, B. X., Mitton, B., Ikeda, A., & Sakamoto, K. M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791208535 · Cited by 160
“Studies with CRE-decoy oligonucleotides demonstrated that normal cells are not sensitive to CREB inhibition [49].”
BackgroundEffects of anticancer drugs on transcription factor–DNA interactions
Gniazdowski, M., Denny, W. A., Nelson, S. M., & Czyz, M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.471 · Cited by 41
“Cyclic AMP response element binding protein (CREB) is effectively trapped by a single-stranded oligonucleotide of palindromic consensus sequence that forms a hairpin double-stranded structure and specifically inhibits CREB and AP-1 controlled transcription in the cell [109].”
BackgroundTranscription Factors and DNA Repair Enzymes Compete for Damaged Promoter Sites
Moore, S. P. G., Kruchten, J., Toomire, K. J., & Strauss, P. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.672733 · Cited by 28
Metadata
- Authors
- Park, Y. G., Nesterova, M., Agrawal, S., & Cho-Chung, Y. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 274
- Issue
- 3
- Pages
- 1573-1580
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2030118774
- Cited by
- 126
- References
- 1
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.